Rhumbline Advisers Has $2.79 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Rhumbline Advisers lowered its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 3.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 117,627 shares of the company’s stock after selling 4,225 shares during the period. Rhumbline Advisers owned approximately 0.09% of Surgery Partners worth $2,794,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. State of Wyoming raised its position in shares of Surgery Partners by 94.4% during the fourth quarter. State of Wyoming now owns 4,002 shares of the company’s stock valued at $85,000 after buying an additional 1,943 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. raised its position in Surgery Partners by 12.1% in the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company’s stock worth $91,000 after purchasing an additional 465 shares in the last quarter. GAMMA Investing LLC raised its position in Surgery Partners by 7,902.7% in the first quarter. GAMMA Investing LLC now owns 8,883 shares of the company’s stock worth $211,000 after purchasing an additional 8,772 shares in the last quarter. Tower Research Capital LLC TRC raised its position in Surgery Partners by 279.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company’s stock worth $228,000 after purchasing an additional 7,925 shares in the last quarter. Finally, Empowered Funds LLC acquired a new position in Surgery Partners in the fourth quarter worth about $245,000.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Tuesday, March 25th. Macquarie decreased their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 11th. Barclays decreased their price objective on shares of Surgery Partners from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 27th. Finally, Benchmark reaffirmed a “buy” rating and set a $35.00 price objective on shares of Surgery Partners in a research note on Monday, April 21st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average target price of $33.56.

Surgery Partners Price Performance

SGRY opened at $22.74 on Monday. Surgery Partners, Inc. has a one year low of $19.50 and a one year high of $33.97. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The company’s 50 day simple moving average is $22.42 and its 200-day simple moving average is $22.75. The stock has a market capitalization of $2.91 billion, a P/E ratio of -47.38, a price-to-earnings-growth ratio of 19.21 and a beta of 1.93.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $776.00 million for the quarter, compared to the consensus estimate of $777.77 million. During the same period last year, the company earned $0.10 earnings per share. Surgery Partners’s revenue for the quarter was up 8.2% compared to the same quarter last year. Sell-side analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.